BACKGROUND: Demographic differences in management of concomitant lipid disorders among hypertensive patients may contribute to health disparities. OBJECTIVES: Assess demographic differences in lipid control rates and treatment patterns among dyslipidemic hypertensive patients in primary care. METHODS: Demographic information, blood pressure, LDL-cholesterol, and medications were obtained on 72,351 hypertensive patients from 262 primary care providers at 69 sites in the Southeast. Analysis focused on a dyslipidemic hypertensive subset. RESULTS: Among 72,351 hypertensives, 38,116 were dyslipidemic. Fifty-two percent of patients did not have a cholesterol measurement documented in the past year. Women and patients <40 years old were less likely to have an annual cholesterol measurement than men and older, same-race counterparts (P < or = .001). Thirty-five percent of all hypertensive dyslipidemic patients had not been prescribed any anti-lipidemic medication, whereas 15% were on a statin and another anti-lipidemic. Women received fewer statin prescriptions than men (47.7% vs 65.1%, P < or = .0001). Fewer African Americans (AA) than Caucasians (C) reached LDL levels of <100 or <130 mg/dL (P < or = .0001). Among C and AA patients, those <40 years old were less likely than older, same-race counterparts to have reached LDL < 100 or <130 mg/dL (p < or = 001). Younger patients had fewer annual cholesterol measurements and were less likely to receive antilipidemic medication and to have LDL controlled than older, same-race counter-parts in each ethnic group (P < or = .0001). CONCLUSIONS: Demographic characteristics of hypertensive patients, especially younger age group, are associated with significant differences in diagnostic testing, treatment, and control of hyperlipidemia in primary care. This primary care information can be used to guide education and policy interventions to improve outcomes and reduce disparities.
BACKGROUND: Demographic differences in management of concomitant lipid disorders among hypertensivepatients may contribute to health disparities. OBJECTIVES: Assess demographic differences in lipid control rates and treatment patterns among dyslipidemic hypertensivepatients in primary care. METHODS: Demographic information, blood pressure, LDL-cholesterol, and medications were obtained on 72,351 hypertensivepatients from 262 primary care providers at 69 sites in the Southeast. Analysis focused on a dyslipidemic hypertensive subset. RESULTS: Among 72,351 hypertensives, 38,116 were dyslipidemic. Fifty-two percent of patients did not have a cholesterol measurement documented in the past year. Women and patients <40 years old were less likely to have an annual cholesterol measurement than men and older, same-race counterparts (P < or = .001). Thirty-five percent of all hypertensive dyslipidemicpatients had not been prescribed any anti-lipidemic medication, whereas 15% were on a statin and another anti-lipidemic. Women received fewer statin prescriptions than men (47.7% vs 65.1%, P < or = .0001). Fewer African Americans (AA) than Caucasians (C) reached LDL levels of <100 or <130 mg/dL (P < or = .0001). Among C and AA patients, those <40 years old were less likely than older, same-race counterparts to have reached LDL < 100 or <130 mg/dL (p < or = 001). Younger patients had fewer annual cholesterol measurements and were less likely to receive antilipidemic medication and to have LDL controlled than older, same-race counter-parts in each ethnic group (P < or = .0001). CONCLUSIONS: Demographic characteristics of hypertensivepatients, especially younger age group, are associated with significant differences in diagnostic testing, treatment, and control of hyperlipidemia in primary care. This primary care information can be used to guide education and policy interventions to improve outcomes and reduce disparities.
Authors: Huifen Wang; Lyn M Steffen; David R Jacobs; Xia Zhou; Henry Blackburn; Alan K Berger; Kristian B Filion; Russell V Luepker Journal: Am J Epidemiol Date: 2011-01-27 Impact factor: 4.897
Authors: Sara E Schaefer; Melissa Salazar; Christine Bruhn; Dennis Saviano; Carol Boushey; Marta D Van Loan Journal: J Immigr Minor Health Date: 2008-05-28
Authors: Samuel N Forjuoh; Charles Huber; Jane N Bolin; Shivajirao P Patil; Manisha Gupta; Janet W Helduser; Sonia Holleman; Marcia G Ory Journal: Patient Educ Couns Date: 2010-09-21
Authors: Brent M Egan; Marilyn A Laken; C Shaun Wagner; Sheryl S Mack; Kim Seymour-Edwards; John Dodson; Yumin Zhao; Daniel T Lackland Journal: J Clin Hypertens (Greenwich) Date: 2011-07-11 Impact factor: 3.738
Authors: Janet Pregler; Karen M Freund; Mary Kleinman; Maureen G Phipps; Rose S Fife; Becky Gams; Ana E Núñez; Margaret R Seaver; Cathy J Lazarus; Nancy C Raymond; Joan Briller; Sebastian Uijtdehaage; Cindy S Moskovic; Gretchen Guiton; Michele David; Geralde V Gabeau; Stacie Geller; Kelli Meekma; Christopher Moore; Candace Robertson; Gloria Sarto Journal: J Womens Health (Larchmt) Date: 2009-10 Impact factor: 2.681
Authors: Barry L Carter; Christopher S Coffey; Liz Uribe; Paul A James; Brent M Egan; Gail Ardery; Elizabeth A Chrischilles; Dixie Ecklund; Mark Vander Weg; Thomas Vaughn Journal: J Clin Hypertens (Greenwich) Date: 2013-04-01 Impact factor: 3.738